Dr. Michael D. Frost, MD, FAAN, FAAP, FAES

Expert Publications

• The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey.
• Tuberous sclerosis complex: a survey of health care resource use and health burden.
• Caring for Children With Tuberous Sclerosis Complex: What Is the Physical and Mental Health Impact on Caregivers?
• Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.

Media Releases

Get to know Pediatric Neurologist Dr. Michael D. Frost, who serves patients in Saint Paul, Minnesota.

Dr. Frost, a board-certified pediatric neurologist, is licensed to practice medicine in Arizona, Colorado, Minnesota, North Dakota, and South Dakota. He is currently the Medical Director of Pediatric Inpatient Epilepsy Services and the Epilepsy Monitoring Unit at Children’s Minnesota Saint Paul Hospital as well as the Associate Medical Director of Neurosciences with the Children’s Minnesota Saint Paul Hospital.

Professionally speaking, he has also been a part of the founding team at Minnesota Epilepsy Group in Saint Paul since 1991. Staff members draw on a vast range of expertise and decades of combined experience to treat patients with epilepsy for whom traditional modes of treatment have proven unsuccessful. 

A member of the Child Neurology Society, the doctor is a Fellow of the American Academy of Neurology (FAAN), a Fellow of the American Academy of Pediatrics (FAAP), and a Fellow of the American Epilepsy Society (FAES).

In regards to his educational background, Dr. Frost graduated with his medical degree from St. Louis University School of Medicine in 1975 and performed his residency in pediatrics at Children’s Mercy Hospital in Kansas City, Missouri in 1977. From there, he went on to complete his residency in child neurology in 1980 at the University of Colorado Health Sciences Center and Affiliated Hospitals in Denver.

Following his education, he attained board certification in epilepsy, neurology with special competency in child neurology, and clinical neurophysiology by the American Board of Psychiatry and Neurology, which is a not-for-profit corporation dedicated to promoting high-quality patient care for the public through the initial and continuing certification of psychiatrists and neurologists. In addition, he attained board certification in pediatrics by the American Board of Pediatrics, which is an independent and non-profit organization that serves as one of the 24 certifying boards of the American Board of Medical Specialties.

Among his current roles and responsibilities, Dr. Frost serves as the Medical Director of the Tuberous Sclerosis Complex Clinic Without Walls and is on the Professional Advisory Board for the Tuberous Sclerosis Alliance. He is also the Medical Director for Camp Oz (the only residential camp in Minnesota for children with epilepsy), an Attending Physician at Children’s Minnesota Hospital, as well as a Clinical Professor of Neurology at the University of Minnesota. His research interests include the use of new anticonvulsant medications, epilepsy surgery, and new treatments for tuberous sclerosis complex.

Pediatric neurology or child neurology refers to a specialized branch of medicine that deals with the diagnosis and management of neurological conditions in neonates (newborns), infants, children, and adolescents. The discipline of child neurology encompasses diseases and disorders of the spinal cord, brain, peripheral nervous system, autonomic nervous system, muscles, and blood vessels that affect individuals in these age groups. A pediatric neurologist is a doctor who treats children who have problems with their nervous system.

Recommended Articles

• Study Discovers Fatality Predictors in Duchenne Muscular Dystrophy

  A recent study published in the Journal of the American Heart Association has demonstrated that high cardiac biomarkers, coupled with low BMI and a poor respiratory profile are important risk factors that could put Duchenne muscular dystrophy patients at risk of premature death.Duchenne muscular...

• Teen with Spinal Muscular Atrophy Being Kept Alive with Spinraza

  Many researchers and medical professionals today are constantly striving to better the opportunities for those diagnosed with a variety of diseases and conditions.  As time has progressed, these treatments have improved in their effectiveness, especially as those in the medical world begin to...

• A Great Resource for Muscular Dystrophy Patients and Caregivers

  There is a group of diseases which fall into the ‘neuromuscular disorders’ category and that are characterized by symptoms which, either directly or indirectly, impair the functioning of the muscles. The direct effect would be via the pathology of the voluntary muscle itself, while the indirect...

• Discover the Fundraiser Dedicated to Finding a Cure for Duchenne Muscular Dystrophy

  Duchenne is one of the lesser-known degenerative diseases which revolves mainly around rapidly-progressing muscular dystrophy and belongs to the same category as similar conditions — such as Becker Muscular Dystrophy — though it is usually one of the most aggressive variations. The disease...

• Infant Botulism: Causes and Treatment

  What is infant botulism?Infant botulism is a serious illness in babies when they ingest Clostridium botulinum, a type of bacteria that produce harmful toxins in the body. The illness causes breathing problems and muscle weakness. However, this condition is quite rare. Each year, less than 100 infant...

• Breakthrough Research on Facioscapulohumeral Muscular Dystrophy

  A study which was recently published in the Natural Communications journal, outlines a major breakthrough in research around facioscapulohumeral muscular dystrophy, also known as FSHD.The study was performed by the University of Minnesota Medical School. Researchers at the university inserted the...